Tag: COVID19
Incyte plans Phase III trial of blood cancer drug as potential...
A paper published last month suggested that one of the reasons behind severe Covid-19 disease might be cytokine storm, a kind of out-of-control immune...
Unlike FDA, European regulators refuse to clear chloroquine for COVID-19 without...
Chloroquine and hydroxychloroquine have drawn more attention—and certainly more presidential support—than any other drug during the global quest to find an effective coronavirus therapy.
Now, days after...
Amgen, Adaptive to develop Covid-19 drugs using antibodies from recovered patients
One of the largest biotechnology companies in the country is tapping a longstanding partnership with another firm to develop treatments for Covid-19.
Thousand Oaks, California-based...
As Covid-19 hinders clinical trial operations, research staff are finding themselves...
People waiting to get tested at Elmhurst Hospital Center in Queens, New York City, which has been flooded with patients due to Covid-19
With Covid-19...
FDA gives emergency use authorization to malaria drugs for Covid-19
A pharmacy employee in Paris holds up a box of chloroquine
The Food and Drug Administration has granted an emergency use authorization to a drug...
FDA says patients can self-administer Covid-19 tests, but not at home
A close-up view of a swab used by medical workers tend to administer the coronavirus test at the drive-in center at ProHealth Care on...
Intercept’s hotly anticipated NASH drug has to wait for its FDA...
Intercept Pharmaceuticals and its closely watched nonalcoholic steatohepatitis (NASH) candidate have hit another snag, this one courtesy of the coronavirus pandemic.
The FDA has put...